Senior care is becoming one of the biggest market shifts in America, and Spiro Senior Care CEO Chris Fox believes the current system isn’t ready for what’s coming. In this Executive Edge interview, Fox explains how Spiro is using AI-driven healthcare, primary care inside senior living facilities, and a “treat in place” model to help … Read more
IREN (NASDAQ:IREN) is trying to prove it can become far more than a Bitcoin mining company. Its Dell Blackwell agreement could help unlock a much larger AI cloud opportunity, but the stock’s surge means investors are already pricing in major success. Stock prices used were the market prices of June 1, 2026. The video was … Read more
Tempus AI (NASDAQ:TEM) sits at the intersection of artificial intelligence, genomics, oncology, and drug development. That combination has created a compelling growth story, especially as the company expands artificial intelligence tools and biopharma partnerships. The stock’s challenge is simple: growth is impressive, but Wall Street still needs proof that the model can scale profitably. Stock … Read more
Micron (NASDAQ:MU) is riding one of the market’s most exciting AI memory stories, but its Virginia expansion points to a broader opportunity. The company isn’t just chasing data center demand. It’s also targeting industries that need reliable long-term memory supply, including defense, automotive, aerospace, industrial equipment, and medical devices. Stock prices used were the market … Read more
Advanced Micro Devices (NASDAQ:AMD) may be entering the most important phase of its AI story. Training grabbed the early spotlight, but inference could drive continuous demand across data centers. That creates a powerful setup for AMD, though the valuation now leaves little room for disappointment. Stock prices used were the market prices of May 29, … Read more
Marvell (NASDAQ:MRVL) has become a serious artificial intelligence infrastructure story as custom silicon, optical networking, and data center demand reshape its growth profile. The stock’s rally reflects rising confidence that hyperscalers need more efficient alternatives to general-purpose graphics processing units, but the valuation now forces investors to ask whether the upside still outweighs the risk. … Read more
Applied Digital (NASDAQ:APLD) has become one of the market’s most dramatic AI infrastructure stories after a massive rally and a new hyperscaler lease. The bullish thesis is simple but powerful: long-term contracted demand, scarce AI data center capacity, and a backlog that could support years of growth. The harder question is whether investors are already … Read more
Poet Technologies (NASDAQ:POET) is trying to move beyond its development-stage reputation and prove that its optical technology can serve the next wave of AI data centers. The Lumilens order has revived the bull case, but investors still have to weigh weak current revenue, dilution, and the pressure to scale production. Stock prices used were the … Read more
Meta (NASDAQ:META) faces one of the clearest investor dilemmas in big tech. The CapEx numbers look intimidating, but the company isn’t chasing AI without a business model. It’s embedding AI directly into advertising, where the money already flows and where even small improvements can create meaningful upside. Stock prices used were the market prices of … Read more
Hims & Hers Health (NYSE:HIMS) is facing one of the most important moments in its growth story. The stock has fallen sharply, margins are under pressure, and investors are questioning whether GLP-1 demand can become a durable profit engine. But subscriber growth, positive cash flow, and international expansion still leave room for a much bigger … Read more
You Found Me :)
Now Let's Grow Your Wealth
Learn to invest like the pros—even if you're just starting.
